Company Filing History:
Years Active: 2003-2006
Title: Kazuto Okimoto: Innovator in Pharmaceutical Chemistry
Introduction
Kazuto Okimoto is a notable inventor based in Nara, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of stable vitreous forms of bradykinin antagonists. With a total of 2 patents, his work has implications for the production of high-quality medicinal products.
Latest Patents
Kazuto Okimoto's latest patents focus on the vitreous form of a known bradykinin antagonist. The first patent describes a vitreous form of 8-[3-[N-[(E)-3-(6-acetamidopyridin-3-yl)acryloylglycyl]-N-methylamino]-2,6-dichlorobenzyloxy]-2-methylquinoline (FR173657). This invention emphasizes the good solid stability of the vitreous form, making it suitable for producing and supplying FR173657 products with stable quality for medicinal use. The second patent also relates to a vitreous form of the compound FR 173657, reinforcing its utility in the pharmaceutical industry.
Career Highlights
Throughout his career, Kazuto Okimoto has worked with prominent companies in the pharmaceutical sector. He has been associated with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Kazuto has collaborated with esteemed colleagues such as Norio Ohnishi and Osamu Aoki. Their joint efforts have further advanced the research and development of pharmaceutical products.
Conclusion
Kazuto Okimoto's contributions to the field of pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a significant inventor. His work continues to influence the development of stable medicinal products, showcasing the importance of innovation in healthcare.